InVirtuoLabs

0 reviews

InVirtuoLabs is revolutionizing drug discovery by integrating advanced artificial intelligence with molecular simulations. Their proprietary platform combines machine learning techniques—such as multimodal learning, active learning, and generative chemistry—with physics-based simulations to efficiently explore vast chemical spaces. This synergy enables rapid identification and optimization of promising drug candidates, significantly accelerating the development of life-changing therapies. Key Features and Functionality: - InVirtuoMOL: A molecular machine learning engine that swiftly evaluates critical properties of potential drug candidates, reducing processing time by 90%. - InVirtuoGEN: A multimodal generative AI module capable of generating up to 1 billion novel molecules per day, expanding the exploration of chemical spaces. - InVirtuoSIM: A physics-based simulation workflow providing detailed insights into drug-target interactions at the atomic level, enhancing predictive models and reducing late-stage failures. Primary Value and Solutions: InVirtuoLabs addresses the challenges of traditional drug development by significantly reducing both the time and cost associated with bringing new drugs to market. Their platform has demonstrated the potential to double success rates compared to conventional methods, cutting development costs—currently exceeding €2.4 billion per drug—and shortening development timelines, which average 12 years. By leveraging AI and molecular simulations, InVirtuoLabs makes drug discovery faster, more precise, and economically sustainable, ultimately making innovative treatments more accessible to patients worldwide.